Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

GE Revolution Ascend

GE Revolution Ascend

Enovacom EPC

Enovacom EPC

Diagnostics

QEII acquires MR Fusion tech for prostate biopsies

November 30, 2022


Dr Greg BaillyHALIFAX – Nova Scotia Health’s QEII Health Sciences Centre made history again this fall, becoming the first hospital in Atlantic Canada to use advanced, real-time technology that fuses magnetic resonance images with ultrasound images, to allow more precise guided biopsies of suspected prostate cancer.

Thanks to a collaboration by the departments of urology and diagnostic imaging, Nova Scotia Health’s Information Management and Technology team (IM/IT) and the QEII Foundation, the QEII Health Sciences Centre has purchased new technology that fuses MR images of the prostate with ultrasound-guided biopsy images, allowing much clearer, live visualization of the biopsy needle path.

The system, one of only a few adopted into clinical practice in Canada, will be used for select patients meeting the criteria, who are referred by their urologist.

Prostate cancer is among the most common and treatable forms of cancer and this technology is allowing Nova Scotia to remain current with the latest standards and technology to support timely diagnosis and treatment.

“This is a huge step forward in providing the absolute best care for our patients, leading to early detection of prostate cancer and better treatment outcomes, as good as any other hospital in North America,” said Dr. Greg Bailly (pictured), chief of urology for Nova Scotia Health’s Central Zone, who led the push for the technology. “We are grateful to the QEII Foundation donors for supporting this emerging standard of care for our patients.”

Generous QEII Foundation donors funded approximately $450,000 of the $600,000 cost of the new equipment and software.

“QEII Foundation donors continue to step up and help healthcare in the region reach new heights,” said Susan Mullin, president and CEO, QEII Foundation. “The real impact of this milestone is the patients who are accessing the best treatment with the hopes of the best outcomes possible. We are grateful to work with donors who share our vision to transform healthcare and today’s new treatment for prostate cancer is just one example of philanthropy at its best.”

QEII radiologists Dr. Andreu Costa and Dr. Mike Rivers-Bowerman completed these milestone procedures and were also heavily involved in the planning.

“In cases where traditional ultrasound alone is not enough, this fusion system allows us to target a specific area in the prostate gland with a high degree of accuracy, allowing for more reliable biopsy results to guide optimal management,” said Dr. Costa.

Prostate cancer is the most common cancer in men, with one in seven being diagnosed in their lifetime. The QEII will perform approximately 500 biopsies per year with the new MR Fusion technology.

PreviousNext

WP 900×150

WP 900x150

News and Trends

  • RACE streamlines patient journey
  • Healthcare supply chain needs a re-think, observers say
  • EDI spots pricing anomalies in Ontario’s healthcare supply chain
  • AI centres of excellence and companies collaborate on apps
  • Talking Stick: New hope for Indigenous mental healthcare
More from the Print Edition

Subscribe

Subscribe

Free of charge to Canadian hospital managers and executives in nursing homes and home-care organizations. Learn More

Follow us on Social Media!

Follow us on Social Media!

CAN Health Network

CAN Health Network

Nihi Data [Winter 2023]

Nihi Data [Winter 2023]

Advertise with us

Advertise with us

Sectra One Cloud

Sectra One Cloud

Change Healthcare [2]

Change Healthcare [2]

Infoway [Feb2023]

Infoway [Feb2023]

CHT print-200×400

CHT print-200x400

WP 900×150

WP 900x150

Advertise with us

Advertise with us

Sectra One Cloud

Sectra One Cloud

Change Healthcare [2]

Change Healthcare [2]

Infoway [Feb2023]

Infoway [Feb2023]

CHT print-200×400

CHT print-200x400

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 207
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2023 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us